BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28223316)

  • 1. Energy metabolism drives myeloid-derived suppressor cell differentiation and functions in pathology.
    Sica A; Strauss L
    J Leukoc Biol; 2017 Aug; 102(2):325-334. PubMed ID: 28223316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid-Derived Suppressor Cells: Ductile Targets in Disease.
    Consonni FM; Porta C; Marino A; Pandolfo C; Mola S; Bleve A; Sica A
    Front Immunol; 2019; 10():949. PubMed ID: 31130949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the origin of myeloid-derived suppressor cells.
    Millrud CR; Bergenfelz C; Leandersson K
    Oncotarget; 2017 Jan; 8(2):3649-3665. PubMed ID: 27690299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of Interferon Regulatory Factor-8 Expression in Myeloid-Tumor Interactions.
    Abrams SI; Netherby CS; Twum DY; Messmer MN
    J Interferon Cytokine Res; 2016 Jul; 36(7):442-53. PubMed ID: 27379866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rab7 GTPase controls lipid metabolic signaling in myeloid-derived suppressor cells.
    Ding X; Zhang W; Zhao T; Yan C; Du H
    Oncotarget; 2017 May; 8(18):30123-30137. PubMed ID: 28415797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid-derived suppressor cells: The green light for myeloma immune escape.
    Malek E; de Lima M; Letterio JJ; Kim BG; Finke JH; Driscoll JJ; Giralt SA
    Blood Rev; 2016 Sep; 30(5):341-8. PubMed ID: 27132116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the Differentiation, Expansion, Recruitment and Suppressive Activities of Myeloid-Derived Suppressor Cells in Cancers.
    Lim HX; Kim TS; Poh CL
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumors.
    Wu T; Zhao Y; Wang H; Li Y; Shao L; Wang R; Lu J; Yang Z; Wang J; Zhao Y
    Sci Rep; 2016 Feb; 6():20250. PubMed ID: 26833095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Granulocyte Progenitor Stage Is a Key Target of IRF8-Mediated Regulation of Myeloid-Derived Suppressor Cell Production.
    Netherby CS; Messmer MN; Burkard-Mandel L; Colligan S; Miller A; Cortes Gomez E; Wang J; Nemeth MJ; Abrams SI
    J Immunol; 2017 May; 198(10):4129-4139. PubMed ID: 28356386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Multiple Cytokine Combinations and TGF-β on Differentiation and Functions of Myeloid-Derived Suppressor Cells.
    Lee CR; Lee W; Cho SK; Park SG
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29543758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle Systems Modulating Myeloid-Derived Suppressor Cells for Cancer Immunotherapy.
    Wilkerson A; Kim J; Huang AY; Zhang M
    Curr Top Med Chem; 2017; 17(16):1843-1857. PubMed ID: 27875974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid-Derived Suppressor Cells Are Controlled by Regulatory T Cells via TGF-β during Murine Colitis.
    Lee CR; Kwak Y; Yang T; Han JH; Park SH; Ye MB; Lee W; Sim KY; Kang JA; Kim YC; Mazmanian SK; Park SG
    Cell Rep; 2016 Dec; 17(12):3219-3232. PubMed ID: 28009291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytochemicals inhibit the immunosuppressive functions of myeloid-derived suppressor cells (MDSC): Impact on cancer and age-related chronic inflammatory disorders.
    Salminen A; Kaarniranta K; Kauppinen A
    Int Immunopharmacol; 2018 Aug; 61():231-240. PubMed ID: 29894862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury.
    Zhang C; Wang S; Li J; Zhang W; Zheng L; Yang C; Zhu T; Rong R
    Cell Death Dis; 2017 Mar; 8(3):e2695. PubMed ID: 28333137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid-derived suppressor cells as effectors of immune suppression in cancer.
    Pyzer AR; Cole L; Rosenblatt J; Avigan DE
    Int J Cancer; 2016 Nov; 139(9):1915-26. PubMed ID: 27299510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-33 inhibits the differentiation and immunosuppressive activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice.
    Lim HX; Choi S; Cho D; Kim TS
    Immunol Cell Biol; 2017 Jan; 95(1):99-107. PubMed ID: 27507556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor Cells.
    Redd PS; Ibrahim ML; Klement JD; Sharman SK; Paschall AV; Yang D; Nayak-Kapoor A; Liu K
    Cancer Res; 2017 Jun; 77(11):2834-2843. PubMed ID: 28381543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma.
    Binsfeld M; Muller J; Lamour V; De Veirman K; De Raeve H; Bellahcène A; Van Valckenborgh E; Baron F; Beguin Y; Caers J; Heusschen R
    Oncotarget; 2016 Jun; 7(25):37931-37943. PubMed ID: 27177328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
    Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
    J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid-derived suppressor cells and tumor escape from immune surveillance.
    Umansky V; Blattner C; Fleming V; Hu X; Gebhardt C; Altevogt P; Utikal J
    Semin Immunopathol; 2017 Apr; 39(3):295-305. PubMed ID: 27787613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.